caus
agent
sever
acut
respiratori
syndrom
sar
identifi
sarsassoci
coronaviru
sarscov
prophylact
treatment
sarscov
still
investig
construct
recombin
adenoviru
contain
truncat
ntermin
fragment
sarscov
spike
gene
design
ad
n
encod
truncat
protein
aminoacid
residu
part
aminoacid
subunit
investig
whether
construct
could
induc
effect
immun
sarscov
wistar
rat
rat
immun
either
subcutan
intranas
ad
n
week
three
consecut
week
result
show
immun
anim
gener
humor
immun
sarscov
spike
protein
sera
immun
rat
show
strong
capabl
protect
sarscov
infect
vitro
histopatholog
examin
find
evid
side
effect
immun
anim
result
indic
adenoviralbas
vaccin
carri
ntermin
fragment
spike
gene
abl
elicit
strong
sarscovspecif
humor
immun
respons
rat
may
use
develop
protect
vaccin
sarscov
infect
sever
acut
respiratori
syndrom
sar
lifethreaten
contagi
diseas
caus
sarsassoci
coronaviru
sarscov
rota
et
al
sinc
first
sar
case
emerg
china
guangdong
provinc
novemb
diseas
affect
victim
countri
devit
near
live
schlagenhauf
ashraf
date
specif
effect
medicin
vaccin
develop
sar
berger
et
al
current
treat
heteropathi
andor
conserv
therapeut
although
first
sar
outbreak
control
main
quarantin
report
http
wwwwpro
whointsarsdocsupdateupd
revisedfinalasp
http
wwwwprowhointsarsdocspressreleasespr
indic
sar
remain
constant
threat
public
effort
develop
safe
effici
sar
vaccin
way
worldwid
marshal
enserink
thu
import
develop
safe
effect
vaccin
sarscov
inactiv
sarscov
vaccin
seem
facil
conveni
option
inactiv
vaccin
associ
risk
infect
exampl
monkey
model
children
immun
inactiv
measl
viru
vaccin
may
develop
sever
case
atyp
measl
polack
et
al
fulgin
et
al
therefor
develop
genebas
vaccin
may
promis
choic
sarscov
genom
singl
strand
rna
molecul
encod
four
structur
protein
spike
glycoprotein
membran
protein
envelop
e
protein
nucleocapsid
n
protein
protein
contain
two
subunit
respons
recogn
bind
receptor
host
cell
direct
fusion
viral
cell
membran
ingallinella
et
al
yang
et
al
angiotensinconvert
enzym
recent
identifi
cellular
receptor
sarscov
li
et
al
receptorbind
region
spike
defin
amino
acid
residu
subunit
solubl
receptor
mab
subunit
interfer
receptor
associ
block
sarscov
infect
hofmann
et
al
sui
et
al
presum
vaccin
design
interfer
bind
protein
receptor
host
cell
would
also
prevent
spread
sar
buchholz
et
al
report
glycoprotein
structur
protein
appear
act
signific
sarscov
neutral
antigen
hamster
model
human
mab
subunit
found
neutral
sar
coronaviru
block
receptor
associ
sui
et
al
moreov
previou
studi
concern
develop
vaccin
anim
coronavirus
suggest
subunit
contain
neutral
epitop
confer
protect
anim
eg
bird
pig
upon
viral
challeng
cavanagh
correa
et
al
delma
et
al
song
et
al
recent
report
viral
express
fulllength
protein
subunit
sar
coronaviru
elicit
high
titer
neutral
antibodi
monkey
model
gao
et
al
howev
almost
lack
safeti
evalu
weingartl
et
al
report
recent
immun
modifi
vaccinia
viru
express
fulllength
spike
protein
sar
viru
associ
enhanc
hepat
develop
rapid
vigor
neutral
antibodi
respons
protein
presum
induc
strong
inflammatori
respons
ferret
liver
tissu
studi
construct
recombin
adenoviru
express
shorter
truncat
subunit
sarscov
ad
n
investig
abil
induc
humor
immun
sarscov
safeti
rat
studi
demonstr
high
titer
antibodi
sarscov
elicit
rat
model
follow
subcutan
sc
intranas
administr
ad
n
latter
target
foster
respiratori
mucos
immun
protect
airborn
diseas
sar
result
indic
construct
could
develop
safe
sarscov
vaccin
cell
line
human
embryon
kidney
cell
line
contain
nucleotid
adenoviru
type
loui
et
al
graham
et
al
cell
line
africa
green
monkey
cell
line
cell
line
purchas
atcc
cultur
rpmi
supplement
fetal
bovin
serum
fb
mm
glutamin
uml
penicillin
gml
streptomycin
c
co
satur
humid
rpmi
supplement
serum
obtain
life
technolog
gibcobrl
wistar
rat
week
old
obtain
experiment
anim
center
sun
yatsen
univers
guangzhou
china
hous
spf
specif
pathogen
free
anim
facil
adenox
tm
express
system
clontech
laboratori
inc
compris
adenoviru
type
genom
delet
region
bp
bp
util
construct
recombin
adenoviru
carri
nucleotid
spike
gene
sarscov
ad
n
vitro
ligat
kay
encod
truncat
subunit
sarscov
protein
ntermin
aminoacid
residu
fig
adlacz
recombin
adenovir
vector
contain
gene
construct
accord
procedur
use
vector
control
two
virus
propag
cell
purifi
csclband
titer
adenox
tm
rapid
titer
kit
bd
bioscienc
inc
eykholt
et
al
prepar
recombin
adenovirus
monitor
prevent
contamin
bacterium
fungu
mycoplasma
wild
type
adenoviru
virus
detect
n
express
mrna
level
cell
infect
recombin
adenovirus
total
cellular
rna
isol
trizol
reagent
invitrogen
digest
rnasefre
dnase
promega
remov
residu
dna
result
mrna
transcrib
cdna
amv
revers
transcriptas
system
invitrogen
oligo
dt
rtpcr
perform
n
specif
primer
gener
bp
dna
fragment
amplifi
primer
ccctca
produc
bp
fragment
assay
intern
control
cell
lysat
cultur
supernat
homogen
tissu
sampl
separ
sdspage
transfer
pvdf
membran
blot
visual
phototopehrp
western
blot
detect
system
new
england
biolab
briefli
blot
block
nonfat
dri
milk
powder
ttb
mm
trishcl
ph
nacl
overnight
c
follow
h
incub
room
temperatur
one
follow
primari
antibodi
rabbit
antispik
igg
abgent
cat
serum
convalesc
sar
patient
sera
ad
n
immun
rat
blot
rins
ttb
solut
incub
hrplink
antirabbithumanrat
igg
santa
cruz
h
rins
blot
incub
lumiglo
tm
new
england
biolab
min
expos
xray
film
rat
n
per
group
intranas
subcutan
immun
ad
n
pfu
control
adlacz
pb
intranas
immun
virus
drop
nose
rat
anim
anaesthet
amylobarbiton
rat
immun
day
sera
collect
day
sarscovspecif
antibodi
igg
titer
enzymelink
immunosorb
assay
elisa
briefli
microtit
plate
coat
sarscov
full
antigen
provid
chines
academi
militari
medicin
chines
academi
scienc
huada
co
ltd
beij
block
pb
ph
contain
bsa
serial
dilut
rat
sera
ad
well
incub
c
min
well
rins
five
time
pbst
pb
contain
tween
follow
min
incub
hrplink
antirat
igg
c
five
time
rins
anoth
min
incub
substrat
solut
c
dark
reaction
termin
stop
solut
optic
densiti
od
determin
use
micropl
reader
set
nm
wavelength
correct
nm
endpoint
titer
defin
reciproc
highest
dilut
result
od
neg
control
sampl
analyz
duplic
neutral
activ
sera
immun
rat
test
vitro
microneutr
assay
briefli
heatinactiv
rat
sera
dilut
twofold
incub
sarscov
stain
c
h
sampl
ad
plate
seed
cell
cellswel
plate
incub
c
day
cytopath
effect
cpe
observ
daili
neutral
titer
measur
reciproc
highest
serum
dilut
complet
inhibit
cell
lysi
least
test
well
procedur
done
biosafeti
level
immuniz
rat
sacrif
day
variou
tissu
includ
lung
liver
colon
heart
brain
spleen
kidney
etc
collect
fix
pbsbuffer
formalin
embed
paraffin
histopatholog
examin
perform
tissu
section
stain
hematoxylin
eosin
construct
recombin
adenovir
vector
ntermin
fragment
sarscov
spike
gene
n
deriv
guangdong
patient
suffer
sar
firstli
clone
xbai
kpni
site
pshuttl
n
express
cassett
clone
padenox
tm
vitro
ligat
uniqu
restrict
site
iceui
piscei
produc
plasmid
pad
n
contain
genom
lack
region
paci
site
end
genom
n
express
cassett
insert
delet
site
fig
pcr
analysi
show
pad
n
contain
n
express
cassett
endonucleas
restrict
digest
gener
expect
fragment
data
shown
sequenc
analysi
show
clone
n
gene
three
variant
base
compar
sarscov
isol
spike
gene
encod
two
deduc
amino
acid
chang
genbank
access
recombin
adenoviru
ad
n
obtain
transfect
pacilinear
pad
n
dna
cell
pcr
analysi
show
recombin
adenoviru
ad
n
contain
insert
n
gene
restrict
analysi
show
ad
n
digest
pattern
pad
n
paci
data
shown
addit
contamin
bacterium
fungu
mycoplasma
wild
type
adenoviru
virus
detect
prepar
ad
n
data
shown
detect
n
vitro
express
transcript
level
cell
infect
ad
n
adlacz
indic
multipl
infect
moi
h
express
n
mrna
test
rtpcr
result
show
n
mrna
detect
cell
total
cellular
rna
isol
n
mrna
detect
rtpcr
amplif
use
intern
control
n
bp
bp
b
cell
infect
ad
n
adlacz
moi
h
cell
cultur
supernat
collect
altern
rat
inject
subcutan
ad
n
adlacz
pfurat
h
tissu
near
inject
site
sampl
homogen
western
blot
use
detect
n
protein
infect
cell
cultur
supernat
rat
tissu
use
phototopehrp
western
blot
detect
system
new
england
biolab
serum
convalesc
sar
patient
row
rabbit
antispik
igg
sar
spike
nterm
antibodi
row
use
primari
antibodi
antiactin
mab
santa
cruz
row
control
infect
ad
n
cell
infect
adlacz
moreov
express
n
mrna
cell
infect
ad
n
dosedepend
fig
detect
express
n
protein
vitro
cell
infect
ad
n
adlacz
moi
h
infect
cell
cultur
supernat
collect
detect
n
protein
express
vivo
rat
inject
subcutan
ad
n
adlacz
pfurat
fourtyeight
hour
later
inject
locu
tissu
sampl
homogen
western
blot
perform
detect
n
protein
variou
sampl
specif
kda
protein
band
consist
predict
size
n
protein
clearli
observ
ad
n
infect
cell
cultur
supernat
ad
n
treat
tissu
visual
commerci
rabbit
antispik
igg
abgent
sera
convalesc
sar
patient
wherea
n
band
found
adlaczinfect
cell
tissu
fig
elisa
analysi
show
sarscovspecif
antibodi
respons
detect
rat
subject
three
sc
immun
ad
n
wherea
specif
immun
respons
found
anim
treat
adlacz
pb
fig
sarscovspecif
igg
detect
ad
ntreat
rat
week
first
immun
level
gradual
increas
maximum
igg
titer
sc
group
respect
week
last
treatment
antibodi
respons
specif
n
protein
ad
nvaccin
rat
test
western
blot
analysi
result
show
sera
ad
n
immun
rat
sc
show
visibl
agab
reaction
n
protein
express
ad
n
infect
cell
fig
sera
adlacztr
pbstreat
rat
data
shown
detect
neutral
activ
sera
immun
rat
sarscov
cell
challeng
sarscov
isol
expect
sera
rat
immun
ad
n
protect
cell
sarscov
stain
challeng
vitro
neutral
titer
sc
group
respect
sera
control
anim
display
neutral
activ
fig
evalu
safeti
ad
n
vaccin
candid
histopatholog
examin
perform
tissu
section
immuniz
rat
evid
patholog
chang
either
ad
n
immun
adlacztr
rat
tissu
data
shown
variou
strategi
explor
search
effect
vaccin
sarscov
includ
use
inactiv
whole
viru
particl
attenu
live
viru
purifi
viral
structur
protein
gene
vaccin
tang
et
al
xiong
et
al
choy
et
al
zhang
et
al
zhou
et
al
yang
et
al
bukreyev
et
al
bisht
et
al
gao
et
al
recent
gene
vaccin
express
sarscov
structur
protein
induc
host
immun
sarscov
becom
increasingli
popular
studi
construct
replicationincompet
recombin
adenoviru
contain
nucleotid
spike
gene
sarscov
name
ad
n
encod
truncat
subunit
sarscov
protein
sequenc
analysi
reveal
clone
n
fragment
three
nucleotid
differ
compar
sarscov
isol
result
two
aminoacid
alter
predict
n
protein
genbank
access
comput
predict
antigen
peptid
kolaskar
tongaonkar
singh
raghava
http
immunaxdfciharvardedutoolsantigenichtml
http
wwwimtechresinraghavapropr
demonstr
variat
influenc
antigen
recombin
protein
secretori
kda
truncat
n
protein
express
cell
rat
infect
ad
n
recogn
rabbit
antispik
igg
sera
convalesc
sar
patient
ad
n
immun
rat
fig
indic
truncat
n
fragment
potenti
antigen
capabl
induc
specif
antibodi
respons
rat
rabbit
human
previou
studi
report
sever
antigen
epitop
spike
protein
recogn
sera
convalesc
sar
patient
capabl
induc
neutral
antibodi
human
hua
et
al
guo
et
al
spike
protein
subunit
report
induc
effici
immun
sarscov
protect
attack
sarscov
anim
model
yang
et
al
bukreyev
et
al
gao
et
al
studi
demonstr
truncat
subunit
spike
protein
ntermin
aminoacid
residu
could
induc
strong
humor
immun
respons
sarscov
rat
fig
b
sera
ad
n
immun
rat
could
effect
protect
cell
sarscov
isol
infect
vitro
fig
evid
patholog
chang
eg
inflammatori
respons
observ
variou
tissu
includ
lung
liver
colon
heart
brain
spleen
kidney
etc
ad
n
immun
anim
data
shown
contrast
find
weingartl
et
al
immun
modifi
vaccinia
viru
express
sarscov
spike
protein
exhibit
strong
inflammatori
respons
liver
tissu
ferret
weingartl
et
al
differ
may
due
differ
experiment
anim
protocol
spike
gene
fragment
vector
carri
present
data
conclus
demonstr
whether
truncat
gene
vaccin
safer
vaccin
candid
howev
presum
truncat
gene
carri
less
risk
spontan
recombin
wild
type
viru
gener
new
viru
type
consid
favorit
truncat
subunit
gene
vaccin
could
safer
vaccin
candid
fulllength
spike
gene
may
act
pharmacolog
activ
vaccin
replicationincompet
adenoviru
vector
wide
use
foreign
gene
carrier
vaccin
xiang
ertl
casimiro
et
al
wu
et
al
previou
work
shown
immun
via
respiratori
tract
ie
intranas
could
induc
protect
mucos
immun
sakau
et
al
bukreyev
et
al
xiang
ertl
respiratori
epitheli
cell
natur
host
adenoviru
recombin
adenoviru
ad
n
immun
respiratori
tract
induc
mucos
immun
first
line
defens
viral
attack
particularli
import
sar
mainli
spread
respiratori
tract
studi
demonstr
sarscovspecif
antibodi
neutral
activ
could
induc
intranas
immun
serum
level
elict
subcutan
immun
fig
c
indic
recombin
adenoviru
encod
truncat
subunit
good
candid
develop
mucos
sarscov
vaccin
clinic
observ
sar
patient
impli
sarscov
seem
elicit
effect
humor
immun
inhibit
cellular
immun
especi
memori
lymphocyt
time
huang
et
al
develop
vaccin
induc
humor
cellular
immun
respons
may
requir
prevent
sarscov
infect
li
et
al
necessari
make
clear
whether
ad
n
elicit
tcell
immun
rat
comprehens
examin
associ
immunolog
paramet
need
evalu
benefit
variou
immun
strategi
addit
rat
model
may
faith
replic
immunolog
characterist
human
necessari
test
potenti
sar
vaccin
candid
immunogen
safeti
efficaci
anim
model
rabbit
primat
raccoon
dog
human
